Suchergebnisse - "Jang, Minyoung"

PubPharm (66)

1

Recent Advances in the Genetic Pathogenesis, Diagnosis, and Management of Esophageal Atresia and Tracheoesophageal Fistula : A Review

enthalten in: Journal of pediatric gastroenterology and nutrition | 2023

von O'Shea, D. | Schmoke, N. | Porigow, C. | +7

2

Follow-up for a Preterm Infant with Subglottic Stenosis

enthalten in: NeoReviews | 2023

von Sebastian, T. | Jang, M. | Kim, F.

3

Cost-effectiveness Analysis of Subcutaneous Infliximab for Inflammatory Bowel Diseases in Sequential Biologic Treatment

enthalten in: Inflammatory bowel diseases | 2023

von Bouhnik, Y. | Atreya, R. | Casey, D. | +5

4

Cost of pediatric laryngotracheal reconstruction : Differences between single-versus double-stage procedures

enthalten in: International journal of pediatric otorhinolaryngology | 2023

von Drake, M. | Lyon, D. | Martin, T. | +4

5

The clinical course of COVID-19 in the outpatient setting: a prospective cohort study

enthalten in: bioRxiv.org | 2022

von Blair, P. | Brown, D. | Jang, M. | +9

6

Budget impact analysis of the subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in the Big-5 European (E5) countries

enthalten in: BMC health services research | 2022

von Yoo, H. | Byun, H. | Caprioli, F. | +5

7

Budget impact analysis of the subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in the Big-5 European (E5) countries

enthalten in: BMC health services research | 2022

von Yoo, H. | Byun, H. | Caprioli, F. | +5

8

Budget impact analysis of the subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in the Big-5 European (E5) countries

enthalten in: BMC health services research | 2022

von Yoo, H. | Byun, H. | Caprioli, F. | +5

9

Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease : a systematic review and meta-analysis

enthalten in: BMC gastroenterology | 2022

von Peyrin-Biroulet, L. | Arkkila, P. | Armuzzi, A. | +13

10

Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis

enthalten in: BMC gastroenterology | 2022

von Peyrin-Biroulet, L. | Arkkila, P. | Armuzzi, A. | +13

1
2
3
4
5
6
7
Nächster »
[7]